Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/124365
Type: | Journal article |
Title: | Vitamin C, Hydrocortisone and Thiamine in Patients with Septic Shock (VITAMINS) trial: study protocol and statistical analysis plan |
Author: | Fujii, T. Udy, A.A. Deane, A.M. Luethi, N. Bailey, M. Eastwood, G.M. Frei, D. French, C. Orford, N. Shehabi, Y. Young, P.J. Bellomo, R. |
Citation: | Critical Care and Resuscitation, 2019; 21(2):119-125 |
Publisher: | The Australasian Medical Publishing Company |
Issue Date: | 2019 |
ISSN: | 1441-2772 2652-9335 |
Statement of Responsibility: | Tomoko Fujii, Andrew A Udy, Adam M Deane, Nora Luethi, Michael Bailey, Glenn M Eastwood, Daniel Frei, Craig French, Neil Orford, Yahya Shehabi, Paul J Young and Rinaldo Bellomo, on behalf of the VITAMINS trial investigators |
Abstract: | Background: Septic shock is associated with poor outcomes. Vitamin C (ascorbic acid) is a cellular antioxidant and has anti-inflammatory properties. Whether the combination therapy of vitamin C, thiamine and hydrocortisone reduces vasopressor dependency in septic shock is unclear. Objectives: To describe the protocol and statistical analysis plan of a multicentre, open-label, prospective, phase 2 randomised clinical trial evaluating the effects of vitamin C, thiamine and hydrocortisone when compared with hydrocortisone monotherapy on the duration of vasopressor administration in critically ill patients with septic shock. Methods: VITAMINS is a multicentre cardiovascular efficacy trial in adult patients with septic shock. Randomisation occurs via a secure website with stratification by site, and allocation concealment is maintained throughout the trial. The primary outcome is the duration of time alive and free of vasopressor administration at Day 7. Secondary outcomes include feasibility endpoints and some patient-centred outcomes. All analyses will be conducted on an intention-to-treat basis. Conclusion: The VITAMINS trial will determine whether combination therapy of vitamin C, thiamine and hydrocortisone when compared with hydrocortisone increases vasopressor-free hours in critically ill patients with septic shock. The conduct of this study will provide important information on the feasibility of studying this intervention in a phase 3 trial. |
Keywords: | VITAMINS trial investigators |
Rights: | © College of Intensive Care Medicine |
Grant ID: | http://purl.org/au-research/grants/nhmrc/GNT1124532 |
Published version: | https://search-informit-com-au.proxy.library.adelaide.edu.au/documentSummary;dn=538871233603730;res=IELHEA |
Appears in Collections: | Aurora harvest 4 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.